Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

by Teresa Amaral, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Domenico Mallardo, Paolo A Ascierto, Piotr Rutkowski, Jason John Luke, Mitchell P Levesque, Roberta Turiello, Elva Morretta, Maria Chiara Monti, Rosa Azzaro, Laurence Imhof, Marc Chevrier, Antje Sucker, Aldo Pinto, Silvana Morello
Published 2020-07-01